Finzati - Logo
XENE logo

Xenon Pharmaceuticals Inc.

XENE • Biotechnology
$59.75
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$5.95B
Growth
-24.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 13.42Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:38 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$59.75
Change0.00%
Shares Out99.61M
Market Cap$5.95B
Enterprise Value$5.03B
52W Range35.10 - 72.66
Beta0.63
P/E-14.54
P/B4.79
P/FCF-13.92
EV/EBITDA-12.06
EV/FCF-11.76

Investment DNA

How strong this company looks for long-term investors

32
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
36/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 13.42Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

XENE
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
100/100
Bullish
Bullish
22
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$60.00
Mean
$84.09
Median
$89.00
High
$100.00

Company Overview

IPO: 11/5/2014
Industry: Biotechnology
P/B i: 4.79
Debt / Equity i: 0.01
Operating Margin: -4974.27%
Net Margin: -4612.13%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 13.42
Quick Ratio: 13.42
Status: Good

Insider Transactions

Recent executive and insider activity

Cannon Gillian
Transaction: 06/05/2026
SELL
Change
-1,190
Price
$53.14
Filing
06/08/2026
Type
SELL
PATOU GARY
Transaction: 06/05/2026
SELL
Change
-1,322
Price
$53.14
Filing
06/08/2026
Type
SELL
Svoronos Dawn
Transaction: 06/03/2026
BUY
Change
+1,593
Price
Not reported
Filing
06/03/2026
Type
BUY